References
- Tomioka S, Yuasa R, Iino Y. Intractable otitis media cases with bronchial asthma. Recent advances in otitis media. In: Mogi G, Honjo I, Ishii T, editors. Proceedings of the Second Extraordinary International Symposium on Recent Advances in Otitis Media. Amsterdam: Kugler Publications; 1993. p. 183–186.
- Tomioka S, Kobayashi T, Takasaka T. Intractable otitis media in patients with bronchial asthma (eosinophilic otitis media). In: Sanna M, editor. Cholesteatoma and Mastoid Surgery. Rome: CIC Edizioni Internazionali; 1997. p. 851–853.
- Iino Y, Tomioka-Matsutani S, Matsubara A, et al. Diagnostic criteria of eosinophilic otitis media, a newly recognized middle ear disease. Auris Nasus Larynx. 2011;38:456–461.
- Nonaka M, Fukumoto A, Ozu C, et al. IL-5 and Eotaxin levels in middle ear effusion and blood from asthmatics with otitis media with effusion. Acta Otolaryngol. 2003;123:383–387.
- Iino Y, Kakizaki K, Katano H, et al. Eosinophil chemoattractants in the middle ear of patients with eosinophilic otitis media. Clin Exp Allergy. 2005;35:1370–1376.
- Ohta N, Ishida A, Kurakami K, et al. Expressions and roles of periostin in otolaryngological diseases. Allergol Int. 2014;63: 171–180.
- Nishizawa H, Matsubara A, Nakagawa T, et al. The role of periostin in eosinophilic otitis media. Acta Otolaryngol. 2012;132: 838–844.
- Ito T, Liu YJ, Arima K. Cellular and molecular mechanisms of TSLP function in human allergic disorders–TSLP programs the “Th2 code” in dendritic cells. Allergology. 2012;61:35–43.
- Friend SL, Hosier S, Nelson A, et al. A thymic stromal cell line supports in vitro development of surface IgM + B cells and produces a novel growth factor affecting B and T lineage cells. Exp Hematol. 1994;22:321–328.
- Sims JE, Williams DE, Morrissey PJ, et al. Molecular cloning and biological characterization of a novel murine lymphoid growth factor. J Exp Med. 2000;192:671–680.
- Kamekura R, Kojima T, Koizumi J, et al. Thymic stromal lymphopoietin enhances tight-junction barrier function of human nasal epithelial cells. Cell Tissue Res. 2009;338:283–293.
- Nakagawa T, Matsubara A, Shiratsuchi H, et al. Intractable otitis media with eosinophils: importance of diagnosis and validity of treatment for hearing preservation. ORL J Otorhinolaryngol Relat Spec. 2006;68:118–122.
- Iino Y, Usubuchi H, Kodama K, et al. Eosinophilic inflammation in the middle ear induces deterioration of bone-conduction hearing level in patients with eosionophilic otitis media. Otol Neurotol. 2009;31:100–104.
- Matsubara A, Nishizawa H, Kurose A, et al. An experimental study of inner ear injury in an animal model of eosinophilic otitis media. Acta Otolaryngol. 2014;134:227–232.
- Kudo N, Mastubara A, Nishizawa H, et al. Immunohistological analysis of eotaxin and RANTES in the model animal of eosinophilic otitis media. Acta Otolaryngol. 2016;137:476–481.
- Allakhverdi Z, Comeau MR, Jessup HK, et al. Thymic stromal lymphopoietin is released by human epithelial cells in response to microbes, trauma, or inflammation and potently activates mast cells. J Exp Med. 2007;204:253–258.
- Tomonaga K, Chaen T, Kurono Y, et al. Type I allergic reactions of the middle ear and eustachian tube: an experimental study. Auris Nasus Larynx. 1990;17:121–131.
- Iino Y, Kakizaki K, Saruya S, et al. Eustachian tube function in patients with eosinophilic otitis media associated with bronchial asthma evaluated by sonotubometry. Arch Otolaryngol Head Neck Surg. 2006;132:1109–1114.
- Kanazawa H, Yoshida N, Shinnabe A, et al. Antigen-specific IgE in middle ear effusion of patients with eosinophilic otitis media. Ann Allergy Asthma Immunol. 2014;113:88–92.